Tofacitinib

Introduction: What is Tofacitinib?

Tofacitinib (lowercase in body) is a medication primarily used to treat autoimmune diseases, particularly rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and polyarticular course juvenile idiopathic arthritis (pcJIA) in patients 2 years and older. It belongs to a class of drugs known as Janus kinase (JAK) inhibitors, which work by interfering with the activity of certain enzymes involved in the inflammatory process. By doing so, Tofacitinib helps reduce inflammation, pain, and other symptoms associated with these chronic conditions.

Uses of Tofacitinib

Tofacitinib is approved for several medical uses, including:

• Rheumatoid Arthritis: It is used in adults who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).
• Psoriatic Arthritis: Tofacitinib is indicated for adults with active psoriatic arthritis who have not responded well to other treatments.
• Ulcerative Colitis: It is also approved for the treatment of moderately to severely active ulcerative colitis in adults who have not responded to other therapies.

How Does It Work?

Tofacitinib works by selectively inhibiting JAK1 and JAK3 enzymes that play a crucial role in the JAK-STAT signaling pathway of various immune cells. When these enzymes are blocked, the inflammatory response is reduced, leading to decreased symptoms such as pain, swelling, and fatigue. In simpler terms, tofacitinib helps modulate the immune system, which can become overactive in autoimmune diseases.

Dosage and Administration

Tofacitinib is typically administered in tablet form. The standard dosages are as follows:

• Rheumatoid Arthritis: 5 mg orally twice daily (BID) is standard; increase to 10 mg BID only if inadequate response and as per safety data.
• Psoriatic Arthritis: The recommended dose is also 5 mg orally twice daily (BID), with a possible increase to 10 mg BID only if inadequate response and per safety data.
• Polyarticular Course Juvenile Idiopathic Arthritis (pcJIA): Weight-based oral solution dosing (e.g., 3.2 mg BID for 10-<20 kg).
• Ulcerative Colitis: The initial (induction) dose is 10 mg orally twice daily (BID) for 8 weeks, followed by a maintenance dose of 5 mg BID (or 10 mg BID if inadequate response). Xeljanz XR equivalent is 11 mg once daily.

Side Effects of Tofacitinib

Like all medications, Tofacitinib can cause side effects.

Common side effects include:

• Headache
• Nausea
• Diarrhea
• Upper respiratory infections
• Increased transaminases (ALT/AST)

Serious side effects may include:

• Increased risk of infections (e.g., tuberculosis, bacterial, viral, or fungal infections)
• Blood clots
• Liver problems
• Anemia, Lymphopenia, Neutropenia
• Malignancies (e.g., lymphoma, skin cancer)
• Major adverse cardiovascular events (MACE)

Patients should report any unusual symptoms to their healthcare provider promptly.

Drug Interactions

Tofacitinib can interact with several medications, which may affect its efficacy or increase the risk of side effects. Major drug interactions include:

• Immunosuppressants: Concurrent use with other immunosuppressive drugs may increase the risk of infections.
• Strong CYP3A4 Inhibitors (e.g., ketoconazole): Increase tofacitinib levels; requires dose reduction to 5 mg once daily. CYP3A4 Inducers (e.g., rifampin): Decrease levels; monitor efficacy.
• Live Vaccines: Patients on Tofacitinib should avoid live vaccines due to the risk of infections.

Always inform your healthcare provider about all the medications and supplements you are taking.

Benefits of Tofacitinib

Tofacitinib offers several clinical and practical advantages:

• Rapid Onset of Action: Many patients experience relief from symptoms within weeks of starting treatment.
• Convenient Administration: The oral tablet form allows for easy self-administration.
• Effective for Multiple Conditions: Tofacitinib is effective for various autoimmune diseases, making it a versatile treatment option.
• Improved Quality of Life: By managing symptoms effectively, Tofacitinib can significantly enhance patients' daily functioning and overall wellbeing.

Contraindications of Tofacitinib

Certain individuals should avoid using Tofacitinib, including:

• Hypersensitivity: Patients with known hypersensitivity to tofacitinib should not use this medication.
• Pregnant or Nursing Women: Safety during pregnancy not established (embryofetal toxicity in animals); recommend effective contraception. Avoid during breastfeeding.
• Severe Liver Disease: Patients with significant liver impairment should not use this medication.
• Active Infections: Individuals with active infections should not start Tofacitinib until the infection is resolved.

Precautions and Warnings

Before starting Tofacitinib, patients should undergo specific lab tests to assess their overall health, including:

• Tuberculosis Screening: Test for latent tuberculosis before and during treatment if risk factors emerge.
• Liver Function Tests: Regular monitoring of liver enzymes is recommended.
• Blood Counts: Periodic blood tests to monitor white blood cells and platelet counts are necessary.

Patients should also be aware of the signs of serious infections and report any symptoms such as fever, chills, or persistent cough to their healthcare provider.

FAQs

• What is Tofacitinib used for? Tofacitinib is used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis in adults.
• How is Tofacitinib taken? Tofacitinib is taken orally in tablet form, usually twice a day or once daily, depending on the condition being treated.
• What are the common side effects? Common side effects include headache, nausea, diarrhea, and upper respiratory infections.
• Can I take Tofacitinib with other medications? Inform your doctor about all medications you are taking, as Tofacitinib can interact with several drugs.
• Is Tofacitinib safe during pregnancy? Safety during pregnancy not established (embryofetal toxicity risks); avoid unless prescribed?use effective contraception.
• How quickly does Tofacitinib work? Many patients may notice symptom relief within a few weeks of starting Tofacitinib.
• What should I do if I miss a dose? If you miss a dose, take it as soon as you remember. If it's almost time for your next dose, skip the missed dose, do not double dose, and continue with your regular schedule.
• Are there any serious risks associated with Tofacitinib? Yes, Tofacitinib can increase the risk of serious infections, blood clots, and liver problems.
• Can I receive vaccinations while on Tofacitinib? Live vaccines should be avoided while taking Tofacitinib. Consult your doctor for guidance on vaccinations.
• How long will I need to take Tofacitinib? The duration of treatment varies depending on individual and condition. Your doctor will determine the appropriate length of the therapy.

Brand Names

Tofacitinib is marketed under several brand names, including:

• Xeljanz
• Xeljanz XR (extended release)
• Zinvo (generic in some markets)

Conclusion

Tofacitinib is a valuable medication for managing autoimmune diseases such as rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Its mechanism of action, ease of use, and rapid onset of relief make it a preferred choice for many patients. However, it is essential to be aware of potential side effects, drug interactions, and contraindications. Always consult your healthcare provider for personalized advice and treatment plans.